GlycoEra
SwitzerlandGlycoEra is a healthcare / biotech company, headquartered in Switzerland.
Entry
2021
Hold
5yr
Status
Active
Est. EV
–
Key facts
HQSwitzerland
SectorHealthcare / Biotech
Swiss company using its CustomGlycan platform to develop novel glycan-mediated biologics for a broad range of indications.
See the full ownership history.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Full fund context: vintage, strategy, region
Already a member? Sign in
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Germany
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
France
BelgiumLast updated April 2026 · Sourced from public filings
Spain
UK
US